Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Poindron

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Rheumatology (Oxford, England)|May 11, 2021
Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patientsDan Levy, Benoit Nespola, Margherita Giannini, et al.
Autoimmunity Reviews|August 18, 2020
Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective studyPhilippe Mertz, Jean-François Kleinmann, Marc Lambert, et al.
Journal of Clinical Immunology|August 27, 2017
Neutropenia in Patients with Common Variable Immunodeficiency: a Rare Event Associated with Severe OutcomeAurélien Guffroy, Rachel Mourot-Cottet, Laurence Gérard, et al.
Nature Communications|November 15, 2024
Defective germinal center selection results in persistence of self-reactive B cells from the primary to the secondary repertoire in Primary Antiphospholipid SyndromeYannick Dieudonné, Raquel Lorenzetti, Julien Rottura, et al.
Bulletin Du Cancer|September 6, 2024
[Prerequisite and organisation of health-care pathways for Cell and Gene therapies, using Mesenchymal Stromal Cells (MSC) or Chimeric Antigen Receptor (CAR) T cells, in patients with autoimmune systemic diseases]Christina Castilla-Llorente, Agnès Bonnin, Pauline Lansiaux, et al.
Autoimmunity Reviews|May 10, 2017
Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patientsPierre-Edouard Gavand, Ilaria Serio, Laurent Arnaud, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2021
Prevalence of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Spatial Association With Quarries in a Region of Northeastern France: A Capture-Recapture and Geospatial AnalysisStéphane Giorgiutti, Yannick Dieudonne, Olivier Hinschberger, et al.
Rheumatology (Oxford, England)|June 5, 2024
Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in systemic lupus erythematosus patientsGelsomina Alle, Gaëlle Guettrot-Imbert, Maddalena Larosa, et al.
RMD Open|August 9, 2023
Invasive fungal diseases in patients with autoimmune diseases: a case series from the French RESSIF networkSimon Galmiche, Benjamin Thoreau, Stéphane Bretagne, et al.
Rheumatology (Oxford, England)|June 24, 2023
Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control studyJulien Culerrier, Yann Nguyen, Omer Karadag, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Rheumatology (Oxford, England)|May 11, 2021
Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patientsDan Levy, Benoit Nespola, Margherita Giannini, et al.
Autoimmunity Reviews|August 18, 2020
Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective studyPhilippe Mertz, Jean-François Kleinmann, Marc Lambert, et al.
Journal of Clinical Immunology|August 27, 2017
Neutropenia in Patients with Common Variable Immunodeficiency: a Rare Event Associated with Severe OutcomeAurélien Guffroy, Rachel Mourot-Cottet, Laurence Gérard, et al.
Nature Communications|November 15, 2024
Defective germinal center selection results in persistence of self-reactive B cells from the primary to the secondary repertoire in Primary Antiphospholipid SyndromeYannick Dieudonné, Raquel Lorenzetti, Julien Rottura, et al.
Bulletin Du Cancer|September 6, 2024
[Prerequisite and organisation of health-care pathways for Cell and Gene therapies, using Mesenchymal Stromal Cells (MSC) or Chimeric Antigen Receptor (CAR) T cells, in patients with autoimmune systemic diseases]Christina Castilla-Llorente, Agnès Bonnin, Pauline Lansiaux, et al.
Autoimmunity Reviews|May 10, 2017
Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patientsPierre-Edouard Gavand, Ilaria Serio, Laurent Arnaud, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2021
Prevalence of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Spatial Association With Quarries in a Region of Northeastern France: A Capture-Recapture and Geospatial AnalysisStéphane Giorgiutti, Yannick Dieudonne, Olivier Hinschberger, et al.
Rheumatology (Oxford, England)|June 5, 2024
Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in systemic lupus erythematosus patientsGelsomina Alle, Gaëlle Guettrot-Imbert, Maddalena Larosa, et al.
RMD Open|August 9, 2023
Invasive fungal diseases in patients with autoimmune diseases: a case series from the French RESSIF networkSimon Galmiche, Benjamin Thoreau, Stéphane Bretagne, et al.
Rheumatology (Oxford, England)|June 24, 2023
Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control studyJulien Culerrier, Yann Nguyen, Omer Karadag, et al.
Pageof 5